BHC (Bausch Health) FFO


BHC Bausch Health Companies Inc BHC
58 GF Score
Price $5.28
GF Value $7.91
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health FFO?

FFO (Funds from operations) only applies to REITs.

BHC
58GF Score
Bausch Health Companies Inc BHC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $5.28 is trading 33.2% below its estimated GF Value™ of $7.91. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for BHC:

  • FFO:
  • GF Value™: $7.91 vs. price of $5.28 (33.2% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score

Get the complete analysis for BHC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.28
Price
$7.91
GF Value